Hamad bin Khalifa University
Dr. Bedognetti received his MD and PhD in Clinical and Experimental Oncology and Hematology from the University of Genoa, Italy. After completing his medical residency in Medical Oncology, he joined the Infectious Disease and Immunogenetics Section (IDIS) of the US National Institutes of Health (NIH) where he completed his post-doctoral fellowship.
Dr. Bedognetti and his team emphasize on identifying molecular mechanisms of immune-resistance and immune-sensitivity in breast cancer, the most prevalent cancer in women of the MENA region. The ultimate goal is to develop novel immunotherapeutic approaches that can improve the prognosis of women affected by this condition.